# OXYGEN DEVELOPMENT, L.L.C. – FDA Inspection, Jan 17, 2018

Source: https://www.keypedia.com/records/fda_inspections/oxygen-development-llc/9deefb7a-9015-45ac-b4cf-eb9d000bd06d
Source feed: FDA_Inspections

> FDA inspection 1039561 of OXYGEN DEVELOPMENT, L.L.C., January 17, 2018. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1039561
- Company Name: OXYGEN DEVELOPMENT, L.L.C.
- Inspection Date: 2018-01-17
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1295654 - 2026-05-19
- [FDA Inspection 1250745 - 2025-09-11](https://www.keypedia.com/records/fda_inspections/oxygen-development-llc/951e75e0-9474-4220-8341-ba8cd5ae30a1)
- FDA Inspection 1042460 - 2018-01-19
- [FDA Inspection 857278 - 2013-11-22](https://www.keypedia.com/records/fda_inspections/oxygen-development-llc/83b1d754-fed3-4709-8a26-932a779f6a8b)
- [FDA Inspection 824681 - 2013-03-29](https://www.keypedia.com/records/fda_inspections/oxygen-development-llc/71aada83-67bb-4e02-ae37-670289f578ea)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/jennifer-l-huntington/c04e1c86-c7ec-4613-b3f7-a1f9ba2b2f2c)

Company: https://www.keypedia.com/companies/oxygen-development-llc/024c27c1-6cfa-4c7b-9daf-9005cbf515b7

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
